|
Market Cap (24-May) $15,228,564 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.064 |
52w Low $0.021 |
P/E - |
EPS 0 |
EMD released this announcement to the ASX on 23 August 2021, 9:11. The announcement is not marked as price sensitive, and is 48 page(s) in length and 5.91MB in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Emyria Drug Development Overview and Webinar | 23 August 2021, 9:11 |
| Emyria Appoints Expert Neuropharmacologist for MDMA Program | 20 August 2021, 8:45 |
| Emyria Executes Pure CBD Agreement with AltaSciences | 13 August 2021, 8:45 |
| CAN: Cann and Emyria mutually end collaboration | 13 August 2021, 8:37 |
You must be logged in to post a reply.
Emyria 